The Joseph Saveri Law Firm filed a class action lawsuit in April 2017 in the U.S. District Court for the Eastern District of Pennsylvania on behalf of U.S. consumers and insurers against Mylan Inc., Mylan Pharmaceuticals Inc. and Sun Pharmaceutical Industries, Inc.
The antitrust suit charges the generic drug manufacturers with conspiring to fix and raise prices for albuterol sulfate tablets, forcing consumers to pay inflated prices for the medication to treat asthma and other breathing problems. U.S. manufacturers have been producing generic albuterol sulfate tablets since patents for the medication expired in 1989. During the one-year period from December 2012 to December 2013, prices for albuterol sulfate tablets skyrocketed by more than 1,000 percent. The manufacturers have maintained these high prices since then.
Consumers blame the companies for engineering price hikes since January 2013, eliminating the benefits of competition and forcing them to pay exorbitant prices.
“Generic manufacturers of albuterol sulfate tablets have illegally conspired to dramatically inflate prices for this essential medication,” says Joseph Saveri, founding partner of the Joseph Saveri Law Firm. “Consumers are being forced to pay unreasonable rates, when generic competition should instead be lowering prices and increasing the availability of prescription drugs.”
Dozens of generic drugs have seen alarming price hikes in recent years, prompting regulatory scrutiny and numerous civil and criminal investigations. In 2016, a generic drug manufacturer reportedly sought leniency from the U.S. government for its role in a generic drug price-fixing conspiracy. Two former pharmaceutical executives pleaded guilty to criminal charges of price-fixing, while the U.S. Attorney General and twenty State AGs filed lawsuits alleging price-fixing among generic drug manufacturers.
The suit, United Benefit Fund v. Mylan Inc., No. 2:17-cv-02158-CMR (E.D. Pa.), seeks treble damages and injunctive relief for affected consumers.
The Joseph Saveri Law Firm is currently investigating several other generic drugs for potential class action claims. Contact the firm at (415) 500-6800, or email us if you have purchased generic drugs that may have been impacted by illegal price-fixing.